LINC01232 and neoplasm: The IHC results of CD8+ in animal transplanted tumor specimens demonstrated that, compared with mice in the vector group, those in the LINC01232‐OE group had significantly lower expression of CD8+; next, NBR1 knockdown with simultaneous LINC01232 overexpression could reverse this phenomenon (Figure 7f,g).